Jpmorgan Chase & CO Health Catalyst, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,238,616 shares of HCAT stock, worth $5.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,238,616
Previous 1,301,181 4.81%
Holding current value
$5.6 Million
Previous $10.6 Million 17.32%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$6.9 - $9.02 $431,698 - $564,336
-62,565 Reduced 4.81%
1,238,616 $8.76 Million
Q3 2024

Dec 26, 2024
BUY
$5.48 - $8.83 $652,547 - $1.05 Million
119,078 Added 10.07%
1,301,181 $10.6 Million
Q3 2024

Nov 08, 2024
BUY
$5.48 - $8.83 $652,547 - $1.05 Million
119,078 Added 10.07%
1,301,181 $10.6 Million
Q2 2024

Dec 26, 2024
SELL
$5.53 - $7.28 $658,501 - $866,887
-119,078 Reduced 9.15%
1,182,103 $7.55 Million
Q2 2024

Aug 12, 2024
BUY
$5.53 - $7.28 $1.18 Million - $1.55 Million
212,939 Added 21.97%
1,182,103 $7.55 Million
Q1 2024

Dec 26, 2024
SELL
$7.44 - $11.21 $2.47 Million - $3.72 Million
-332,017 Reduced 25.52%
969,164 $7.3 Million
Q1 2024

May 10, 2024
SELL
$7.44 - $11.21 $905,336 - $1.36 Million
-121,685 Reduced 11.16%
969,164 $7.3 Million
Q4 2023

Dec 26, 2024
SELL
$6.71 - $10.16 $1.41 Million - $2.14 Million
-210,332 Reduced 16.16%
1,090,849 $10.1 Million
Q4 2023

Feb 12, 2024
SELL
$6.71 - $10.16 $5.96 Million - $9.03 Million
-888,612 Reduced 44.89%
1,090,849 $10.1 Million
Q3 2023

Nov 14, 2023
SELL
$9.35 - $14.32 $1.17 Million - $1.8 Million
-125,663 Reduced 5.97%
1,979,461 $20 Million
Q2 2023

Aug 11, 2023
BUY
$9.86 - $13.12 $2.39 Million - $3.18 Million
242,609 Added 13.03%
2,105,124 $26.3 Million
Q1 2023

May 18, 2023
BUY
$10.23 - $14.76 $704,192 - $1.02 Million
68,836 Added 3.84%
1,862,515 $21.7 Million
Q1 2023

May 11, 2023
SELL
$10.23 - $14.76 $5.87 Million - $8.48 Million
-574,207 Reduced 24.25%
1,793,679 $20.9 Million
Q4 2022

Feb 13, 2023
BUY
$6.86 - $11.32 $6.44 Million - $10.6 Million
938,440 Added 65.65%
2,367,886 $25.2 Million
Q3 2022

Nov 14, 2022
BUY
$9.3 - $18.27 $10.6 Million - $20.9 Million
1,142,719 Added 398.54%
1,429,446 $13.9 Million
Q2 2022

Aug 11, 2022
BUY
$11.79 - $27.63 $1.9 Million - $4.45 Million
161,072 Added 128.19%
286,727 $4.15 Million
Q1 2022

May 11, 2022
BUY
$20.67 - $40.33 $926,904 - $1.81 Million
44,843 Added 55.49%
125,655 $3.28 Million
Q4 2021

Feb 10, 2022
BUY
$36.68 - $54.02 $1.46 Million - $2.16 Million
39,919 Added 97.62%
80,812 $3.2 Million
Q3 2021

Nov 12, 2021
BUY
$49.57 - $58.15 $2.03 Million - $2.38 Million
40,893 New
40,893 $2.05 Million

Others Institutions Holding HCAT

# of Institutions
176
Shares Held
50.5M
Call Options Held
2.97M
Put Options Held
16.1K
View Full List

About Health Catalyst, Inc.

HCAT Quotes by TradingView
  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $247M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email